Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EWI-2 modulates lymphocyte integrin alpha4beta1 functions.

Tatiana V Kolesnikova1, Christopher S Stipp, Ravi M Rao

  • 1Dana-Farber Cancer Institute, Brigham and Women's Hospital, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.

Blood
|April 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Newly identified invasion drivers define the tumor front in oral squamous cell carcinoma.

Cell death discovery·2026
Same author

DHHC3 interferes with antitumor immunity in melanoma cells.

Oncotarget·2026
Same author

A critical role of FAK signaling in Rac1-driven melanoma cell resistance to MAPK pathway inhibition.

Oncogene·2025
Same author

Efficient in vivo generation of CAR T cells using a retargeted fourth-generation lentiviral vector.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

A critical role of FAK signaling in Rac1-driven melanoma cell resistance to MAPK pathway inhibition.

bioRxiv : the preprint server for biology·2025
Same author

EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells.

International journal of molecular sciences·2024

The protein EWI-2 interacts with integrin alpha4beta1 and CD81 in T leukemia cells, affecting cell morphology and motility by reorganizing cell-surface complexes.

Area of Science:

  • Cell biology
  • Immunology

Background:

  • Integrin alpha4beta1 is a key cell-surface receptor involved in cell adhesion and migration.
  • EWI-2 is a protein known to interact with tetraspanin proteins CD9 and CD81.

Purpose of the Study:

  • To identify the prominent cell-surface partner of integrin alpha4beta1 in MOLT-4 T leukemia cells.
  • To investigate the role of EWI-2 in regulating alpha4beta1-mediated cell adhesion and morphology.

Main Methods:

  • Isolation of alpha4beta1-interacting proteins using antibody-coated beads.
  • Mass spectrometry for protein identification.
  • Overexpression studies and shear flow assays to assess cell adhesion and morphology.
  • Size exclusion chromatography to analyze protein complex size and composition.

Related Experiment Videos

Main Results:

  • EWI-2 was identified as the 70-kDa partner of alpha4beta1, also interacting with CD81.
  • EWI-2 overexpression impaired cell spreading and ruffling on VCAM-1 but did not affect adhesion strengthening.
  • A mutant EWI-2 with an altered cytoplasmic tail failed to impair spreading or associate with alpha4beta1 and CD81.
  • EWI-2 induced reorganization of CD81 and increased associations within CD81-alpha4beta1 complexes.

Conclusions:

  • EWI-2 plays a role in regulating integrin alpha4beta1 function by reorganizing cell-surface complexes with CD81.
  • This reorganization by EWI-2 influences integrin-dependent cell morphology and motility.